Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Classificação em ações #42765
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Preço da ação
$0.0001
Última sincronização: 2026-08-11
Valor de mercado
$150.00
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Poniard Pharmaceuticals, Inc. (PARD)

Categoria

Preço PARD com a capitalização de mercado de B
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
PARD
$0.0001
Capitalização de mercado de Poniard Pharmaceuticals, Inc.(PARD)
Valor de mercado: $150.00
Em August 2026, Poniard Pharmaceuticals, Inc. tem uma capitalização de mercado de $150.00. Isso faz com que Poniard Pharmaceuticals, Inc. seja a 42765th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Poniard Pharmaceuticals, Inc. de 1988 a 2026
PARD comparado com o topo de 5 mais populares stocks
Preço para PARD Ativo B Capitalização de mercado de B Resultados
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$3,617,326 $150.00
$5.426T +3,617,325,682,222.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,957,936 $150.00
$4.437T +2,957,935,582,593.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,766,258 $150.00
$4.149T +2,766,257,604,808.67%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,442,560 $150.00
$3.664T +2,442,560,416,900.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$1,926,166 $150.00
$2.889T +1,926,166,325,900.00%